Joel D. Parry
Joel D. Parry publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques and Bioactive Compounds and Antitumor Agents.
- World rank
- #2,220,217 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #160,338 of 367,258
- Works
- 23
- Citations
- 624
- Citations per work
- 27.1
What does Joel D. Parry research?
Joel D. Parry's work is mostly in Biochemistry, Genetics and Molecular Biology (31%), Medicine (22%), Pharmacology, Toxicology and Pharmaceutics (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else938.5%
- Life Sciences835.4%
- Health Sciences521.5%
- Medicine521.5%
- Physical Sciences14.6%
- Chemistry14.6%
- 1Molecular Biology31% of their works
- 2Oncology9% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Toxicology5% of their works
- 5Cardiology and Cardiovascular Medicine5% of their works
- 6Organic Chemistry5% of their works
Research topics
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Bioactive Compounds and Antitumor Agents
- Chemotherapy-induced cardiotoxicity and mitigation
- Inhalation and Respiratory Drug Delivery
- Virus-based gene therapy research
- DNA and Nucleic Acid Chemistry
- CRISPR and Genetic Engineering
Which keywords describe Joel D. Parry's research?
The keywords of their largest research topics: Gene Therapy, Nanoparticles, RNA Interference, siRNA Delivery, DNA nanotechnology, Self-Assembly, Anthracyclines and Doxorubicin.
- Viral Vectors
- Genome Engineering
- DNA Structure
- Toxicology
- Pulmonary Drug Delivery
- Doxorubicin
- Self-Assembly
- siRNA Delivery
- Nanoparticles
- Gene Therapy
- RNA Interference
- DNA nanotechnology
- Anthracyclines
- Inhaler Devices
- Quinones
- AAV
- G-Quadruplexes
- RNA-Guided
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Gene Therapy82 topics
- Nanoparticles82 topics
- RNA Interference61 topic
- siRNA Delivery61 topic
- DNA nanotechnology51 topic
- Self-Assembly51 topic
- Anthracyclines31 topic
- Doxorubicin31 topic
- Inhaler Devices31 topic
- Pulmonary Drug Delivery31 topic
- Quinones31 topic
- Toxicology31 topic
- AAV21 topic
- DNA Structure21 topic
- G-Quadruplexes21 topic
- Genome Engineering21 topic
- RNA-Guided21 topic
- Viral Vectors21 topic
Where does Joel D. Parry work?
Joel D. Parry's main affiliation in the publication record is GlaxoSmithKline (United Kingdom), United Kingdom.
How many publications and citations does Joel D. Parry have?
OpenAlex counts 23 works and 624 citations for Joel D. Parry, an h-index of 9, ranking #2,220,217 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Joel D. Parry. Posts are plain text and can be reported.